Top Quark Forward-Backward Asymmetry and Same-Sign Top Quark Pairs

The top quark forward-backward asymmetry measured at the Tevatron collider shows a large deviation from standard model expectations. Among possible interpretations, a non-universal $Z^\prime$ model is of particular interest as it naturally predicts a top quark in the forward region of large rapidity. To reproduce the size of the asymmetry, the couplings of the $Z^\prime$ to standard model quarks must be large, inevitably leading to copious production of same-sign top quark pairs at the energies of the Large Hadron Collider (LHC). We explore the discovery potential for $tt$ and $ttj$ production in early LHC experiments at 7-8 TeV and conclude that if {\it no} $tt$ signal is observed with 1 fb$^{-1}$ of integrated luminosity, then a non-universal $Z^\prime$ alone cannot explain the Tevatron forward-backward asymmetry.Comment: Tevatron limit from same-sign tt search adde

Actualizing the affordance of mobile technology for classroom orchestration: A main path analysis of mobile learning

Ubiquitous and increasingly accessible, mobile technology enhanced learning in the learning process, referred to as classroom orchestration, is inspiring an increasing number of studies that examines mobile learning from various perspectives. Nonetheless, educators find themselves confronted by the ever-evolving features of mobile technology and challenges in implementation context. This study, therefore, surveys the research literature on mobile learning using main path analysis, and cites affordance actualization by Strong (Strong et al. 2014) as a theoretical lens to identify the research themes from results found in main paths, to develop a “mobile learning actualization” framework. This particular framework integrates several research themes, ranging from system features, educator and learner, the goal of mobile technology adoption, contextual implementation, to the outcome of mobile learning. These insights have proven constructive for educators to adapt mobile technology to a learning environment, thus successfully achieving classroom orchestration

IT Enabled Service Innovation In E-Government: The Case Of Taiwan Drug Abuse Reduction Service

Drug abuse problem is one of the toughest issues faced by governments in the world. The typical solution is every time when the drug abuse offenders are under arrest, they are jailed for a while. There is high probability that they will repeat the offense after leaving the prison. Thus, such a solution wastes lots of administrative resources from the government, yet still cannot reduce the recidivism of drug abuse. Nowadays, most countries treat drug abuse offenders as patients, and offer them substitute treatment in order to reduce the dependence on drug and also reduce the risk of infecting AIDS. The patients will go to work as a normal person, live as a normal person, and keep their human dignity. In this study, we introduce the care of Taiwan drug abuse reduction service by service blueprinting method. The service integrates several ministries of Taiwan government in signal information system, and will be triggered automatically when the drug abuse offender is leaving the prison. Subsequently, we analyze the case by the framework of Service Open System View and then provide some suggestions for improvement of the existing service. This study share the case of Taiwan drug abuse reduction service and provide the best practice of improving existing service by the view point of service science to academics

1-(4-Methyl­phenyl­diazo­nium­yl)-2-naphtholate

In the title compound, C17H14N2O, the dihedral angle between the benzene ring and naphthalene ring system is 11.0 (3)°. The azo group adopts an anti configuration and an intra­molecular N—H⋯O hydrogen bond exists. Mol­ecules are packed by π–π inter­actions between adjacent mol­ecule (closest approach between centroids of benzene and naphthalene rings of 3.501 Å)

Urinary excretion of L-carnitine, acetyl-L-carnitine, propionyl-L-carnitine and their antioxidant activities after single dose administration of L-carnitine in healthy subjects

The urine excretion of L-carnitine (LC), acetyl-L-carnitine (ALC) and propionyl-Lcarnitine (PLC) and their relations with the antioxidant activities are presently unknown. Liquid L-carnitine (2.0 g) was administered orally as a single dose in 12 healthy subjects. Urine concentrations of LC, ALC and PLC were detected by HPLC. Superoxide dismutase (SOD), total antioxidative capacity (T-AOC), malondialdehyde (MDA) and nitrogen monoxidum (NO) activities were measured by spectrophotometric methods. The 0~2 h, 2~4 h, 4~8 h, 8~12 h, 12~24 h excretion of LC was 53.13±31.36 µmol, 166.93±76.87 µmol, 219.92±76.30 µmol, 100.48±23.89 µmol, 72.07±25.77 µmol, respectively. The excretion of ALC was 29.70±14.43 µmol, 80.59±32.70 µmol, 109.85±49.21 µmol, 58.65±18.55 µmol, and 80.43±35.44 µmol, respectively. The urine concentration of PLC was 6.63±4.50 µmol, 15.33±12.59 µmol, 15.46±6.26 µmol, 13.41±11.66 µmol and 9.67±7.92 µmol, respectively. The accumulated excretion rate of LC was 6.1% within 24h after its administration. There was also an increase in urine concentrations of SOD and T-AOC, and a decrease in NO and MDA. A positive correlation was found between urine concentrations of LC and SOD (r = 0.8277) or T-AOC (r = 0.9547), and a negative correlation was found between urine LC excretions and NO (r = -0.8575) or MDA (r = 0.7085). In conclusion, a single oral LC administration let to a gradual increase in urine L-carnitine excretion which was associated with an increase in urine antioxidant enzymes and the total antioxidant capacities. These data may be useful in designing therapeutic regimens of LC or its analogues in the future.A excreção urinária de L-carnitina (LC), acetil-L-carnitina (ALC) e propionil-L-carnitine (PLC) e as suas relações com as atividades antioxidantes são presentemente desconhecidos. Líquido de L-carnitina (2,0 g) foi administrada por via oral como uma dose única em 12 indivíduos saudáveis. As concentrações urinárias de LC, PLC e ALC foram detectados por HPLC. Atividades superóxido dismutase (SOD), a capacidade antioxidante total (T-AOC), malondialdeído (MDA) e óxido nítrico (NO) foram medidas por métodos espectrofotométricos. O 0~2 h, 2~4 h, 4~8 h, 8~12 h, 12~24 h excreção de LC foi 53,13±31.36 µmol, 166,93±76.87 µmol, 219,92±76.30 µmol, 100,48±23.89 µmol, 72,07±25.77 µmol, respectivamente. A excreηão de ALC foi 29,70±14.43 µmol, 80,59±32.70 µmol, 109,85±49.21 µmol, 58,65±18.55 µmol, e 80,43±35.44 µmol, respectivamente. A concentraηão de urina de PLC foi 6,63±4.50 µmol, 15,33±12.59 µmol, 15,46±6.26 µmol, 13,41±11.66 µmol e 9,67±7.92 µmol, respectivamente. A taxa de excreηão acumulada de LC foi de 6,1% 24 horas após sua administração. Houve também um aumento nas concentrações de urina de SOD e T-COA e diminuição de NO e de MDA. Correlação positiva foi encontrada entre as concentrações de urina de LC e SOD (r = 0,8277) ou T-AOC (r = 0,9547) e correlação negativa entre a excreção de LC e NO (r = -0,8575) ou MDA (r = 0,7085). Em conclusão, a administração oral única de LC leva ao aumento gradual na excreção urinária de L-carnitina, que foi associada com o aumento das enzimas antioxidantes na urina e as capacidades antioxidantes totais. Estes dados podem ser úteis no futuro para o planejamento de esquemas terapêuticos de LC ou os seus análogos, no futuro